Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details) - Schedule of net proceeds of the public offering

v3.21.2
Stockholders' Equity (Details) - Schedule of net proceeds of the public offering
9 Months Ended
Sep. 30, 2021
USD ($)
Gross Proceeds:  
Firm shares and exercise of over-allotment option closing $ 51,520,000
Offering Costs:  
Underwriting discounts and commissions (3,806,400)
Other offering costs (190,031)
Net Proceeds $ 47,523,569